USE OF THE HIGHLY CONCENTRATED INTRANASAL SPRAY FORMULATION OF DESMOPRESSIN IN MILD HEMOPHILIA-A AND VON-WILLEBRAND DISEASE

被引：0
|
作者：
LUSHER, JM [1 ]
机构：
[1] CHILDRENS HOSP MICHIGAN,DETROIT,MI
来源：
TRANSFUSION | 1995年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [41] EFFICACY OF ALPHANATE(TM) (FACTOR-VIII CONCENTRATE) IN DESMOPRESSIN NONRESPONSIVE VON-WILLEBRAND DISEASE TYPE 2A (IIA AND IIC MIAMI)
    LEDFORD, MR
    BYRNES, JJ
    DELGADO, L
    BRITO, MI
    LIEBMANN, AS
    [J]. BLOOD, 1994, 84 (10) : A198 - A198
  • [42] Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease
    Sharthkumar, A.
    Greist, A.
    Di Paola, J.
    Winay, J.
    Roberson, C.
    Heiman, M.
    Herbert, S.
    Parameswaran, R.
    Shapiro, A.
    [J]. HAEMOPHILIA, 2008, 14 (03) : 539 - 548
  • [43] A prospective comparision of intranasal (IN) and subcutaneous (SC) desmopressin (DDAVP) therapy in type 2M Von Willebrand disease (VWD).
    Parameswaran, Rekha
    Shapiro, Amy D.
    Di Paola, Jorge
    Winay, Jon
    Roberson, Chris
    Greist, Anne
    [J]. BLOOD, 2006, 108 (11) : 308A - 308A
  • [44] Evaluation of Global Hemostasis Assays in Von Willebrand Disease Type 3 in Comparison with Mild to Moderate Hemophilia a
    Baby, Sreya Punjadath
    Dave, Rutvi
    Geevar, Tulasi
    Samuel, Ashok
    Rani, Jansi
    Nair, Sukesh C.
    [J]. BLOOD, 2022, 140 : 11315 - 11316
  • [45] High-dose DDAVP intranasal spray (Stimate®) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A
    Leissinger, C
    Becton, D
    Cornell, C
    Gill, JC
    [J]. HAEMOPHILIA, 2001, 7 (03) : 258 - 266
  • [46] Recessive von Willebrand Disease Type 2 Normandy: Variable Expression of Mild Hemophilia and VWD Type 1
    Michiels, Jan Jacques
    Gadisseur, Alain
    Vangenegten, Inge
    Schroyens, Wilfried
    Berneman, Zwi
    [J]. ACTA HAEMATOLOGICA, 2009, 121 (2-3) : 119 - 127
  • [47] Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A New Insights into Factor VIII-von Willebrand Factor Interactions
    Jacquemin, Marc
    [J]. ACTA HAEMATOLOGICA, 2009, 121 (2-3) : 102 - 105
  • [48] PLATELET RISTOCETIN COFACTOR (RICOF) IN PATIENTS WITH TYPE-I PLATELET NORMAL VON-WILLEBRAND DISEASE CORRELATES WITH PLASMA RICOF PEAK AFTER DESMOPRESSIN INFUSION
    CASTAMAN, G
    RODEGHIERO, F
    [J]. THROMBOSIS RESEARCH, 1995, 77 (04) : 383 - 384
  • [49] Efficacy of Stimate(R) (desmopressin acetate) nasal spray, 1.5 mg/mL, in patients type 1 von Willebrand disease (vWd).
    Kouides, P
    Bernstein, Z
    deAlarcon, P
    Valdez, L
    [J]. BLOOD, 1997, 90 (10) : 3187 - 3187
  • [50] Life-threatening bleeding in a patient with mild hemophilia A and heterozygosity for von Willebrand disease Type 2N
    John N. Allan
    Kenneth D. Friedman
    Maria T. DeSancho
    [J]. International Journal of Hematology, 2014, 100 : 602 - 606
12345